Hyperlipidaemia, atherosclerosis and angina 2 Flashcards
How do statins work?
block cholesterol synthesis in liver by competitively inhibiting HMG-Co A enzyme
How is cholesterol removed from circulation?
increasing LDL receptors on surface and hepatocytes and removing LDL from circulation
How is production of bile acid maintained?
liver compensates by removing cholesterol from circulation
How to statins reduce cardiovascular risk?
reduction of LDL
How do patients benefit?
produce small increases in the serum HDL concentration, reducing triglycerides (TG) and having anti-inflammatory effects that work against atherosclerotic plaque formation and rupture
What do statins end with?
statin
eg: atorvastatin and simvastatin
Who should take statins?
prescribed to reduce the risk that someone will have a heart attack, stroke or develop angina- primary or secondary prevention
Adverse effects of statins (5)
- mild–> headache/GI tract issues
- myalgia (muscle pain)- 10%
- myositis–> muscle inflammation which had progress to rnhabdomylosis
rnhabdomylosis–> muscle breakdown- fatal as breakdown of muscle releases myoglobin to circulation- myoglobin is toxic to the kidney which can lead to acute kidney failure.
- may cause a small increase in the risk of developing type 2 diabetes (10-20% dependent on the particular statin).
Primary prevention
trying to reduce the risk of cardiovascular disease occurring in the first place. The aim here is to reduce non-HDL cholesterol by 40%.
Secondary prevention
reducing the risk of the person’s angina worsening if the disease is already established or reducing the risk of them suffering another heart attack or stroke
the doses of statins for secondary prevention higher than for primary prevention. NICE suggests a non-HDL cholesterol target of 2.6 mmol/L or lower.
NICE guidelines on prevention
for secondary prevention, most people who have had a heart attack or stroke, or have been diagnosed with angina should be prescribed statins
a person who is at risk of developing cardiovascular disease is given statins
depending on QRISK calculator score
If someone’s 10 year risk of developing cardiovascular disease is 10% or higher= give statins
NICE suggested doctors should consider statins for some patients with a QRISK3 score of less than 10%- so number is increasing
Statin and controversy
explosion in press interest in the statins has tended to exaggerate the risk of side effects, resulting in large numbers of people discontinuing their statin treatment
a 2016 review concluded that in the UK, up to 200000 patients had stopped their statin therapy and this could result in 2000-6000 avoidable heart attacks or strokes over the coming decade
Statin substitutions
Although statins are the mainstays of drug treatment for hypercholesterolaemia, there are some patients who cannot tolerate them, or who do not achieve a big enough reduction in non-HDL cholesterol with statins alone
for these people, other drugs need to either be substituted for stains or added including ezetimibe and fibrates
How does ezetimibe work?
blocks the absorption of dietary cholesterol by blocking NPC1L1
Ezetimibe effectiveness
Ezetimibe is less effective on its own than the statins, producing smaller changes in LDL, HDL and triglycerides (TG), so given in combination with the statins
Dual approach - targeting both cholesterol synthesis and absorption of dietary cholesterol - can be effective for patients whose non-HDL cholesterol levels cannot be adequately controlled with statins alone e.g. people with familial hypercholesterolaemia
When is ezetimibe used as sole therapy?
people who cannot tolerate statins as has similar but milder side effects compared to the statins
Dual approach of ezetimibe
targeting both cholesterol synthesis and absorption of dietary cholesterol
Fibrates examples
fenofibrate and gemfibrozil
Fibrates
older class of drugs that used extensively before statins
activate nuclear hormone receptors known as the PPARs
modulate a range of genes involved in lipid metabolism
Effects of fibrates (3)
1) raised HDL
2) lowered triglycerides (TG)
3) smaller effects on LDL cholesterol
Effectiveness of fibrates
not as effective as statins at reducing non-HDL cholesterol so only used when statins cannot be tolerated or in patients with low HDL and high triglycerides
can be combined with statins, but this carries a high risk of rhabdomyolysis and so is only done under supervision by a specialist.
Stable angina problem
some parts of the cardiac muscle do not receive sufficient oxygen because the blood vessels supply that muscle are blocked by atherosclerotic plaques
produces ischaemia which causes chest pain experienced in angina
Outcomes of treatment strategies for stable angina (4)
preventing plaque worsening through the use of lipid-lowering drugs like the statins
using anti-thrombotic drugs to prevent the formation of a thrombus (blood clot) that would lead to a heart attack
using drugs to reduce the workload of the heart and decrease its oxygen needs.
improving blood flow to cardiac muscle using drugs or surgical techniques
Glyceryl trinitrate
unstable high-explosive compound
when used as a medication it is either in a dilute solution or formulated with stabilizers so does not pose any risk of explosion
one of the main-stays of angina treatment and is usually prescribed in a short acting formulation that can relieve an attack of angina or prevent one occurring